To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Neuroendocrine tumors; lymphoma

Cell culture and mouse studies suggest inhibiting SLC7A5 or SLC43A1 could help treat

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE